Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia
about
Experimental treatment of antipsychotic-induced movement disordersDeprescription: The prescription metabolismA systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practiceAssessment and management of behavioral and psychological symptoms of dementiaWhat are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi processAntipsychotic prescribing for Alzheimer's disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study.The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.Deprescribing for older patients.Epidemiology of drug-disease interactions in older veteran nursing home residents.Psychotropic drug use among people with dementia--a six-month follow-up study.Evaluation and management of the elderly patient presenting with cognitive complaints.Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysisThe development and testing of the quality use of medications in dementia (QUM-D): a tool for quality prescribing for behavioral and psychological symptoms of dementia (BPSD).Multi-psychotropic drug prescription and the association to neuropsychiatric symptoms in three Norwegian nursing home cohorts between 2004 and 2011.A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practiceComparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study.Persistent use of psychotropic drugs in nursing home residents in Norway.Improving the management of behaviour that challenges associated with dementia in care homes: protocol for pharmacy-health psychology intervention feasibility study.Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analysesPsychotropic and cognitive-enhancing medication use and its documentation in contemporary long-term care practice.Physicians need to take the lead in deprescribing.A realist evaluation of patients' decisions to deprescribe in the EMPOWER trial.Use of antipsychotics and risk of myocardial infarction: a systematic review and meta-analysis.A Review of Adverse Outcomes Associated with Psychoactive Drug Use in Nursing Home Residents with Dementia.Management of Behavioral and Psychological Symptoms of Dementia.Behavioral and psychological symptoms and psychotropic drugs among people with cognitive impairment in nursing homes in 2007 and 2013.Hallucinations Predict Relapse After Discontinuation of Risperidone in Patients With Alzheimer's Disease and Psychosis or Agitation.The outcome of agitation in poisoned patients in an Iranian tertiary care university hospitalAntipsychotic Use in Dementia.Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline.Efficacy and safety of maintenance electroconvulsive therapy for sustaining resolution of severe aggression in a major neurocognitive disorder.Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms.Barriers to antipsychotic discontinuation in nursing homes: an exploratory study.Déprescription des antipsychotiques pour les symptômes comportementaux et psychologiques de la démence et l’insomnie: Guide de pratique clinique fondé sur des données probantes.Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review.
P2860
Q26740354-B6E53396-517C-4D24-953A-F2DCC7C4248CQ28070294-78523865-5102-4F79-B78A-E64745C481C9Q28078344-725B6938-7162-480D-9044-CD6ACB190468Q28088782-301174C8-1F97-43BB-8117-829BD9B23230Q28545785-F94D3AAF-3C29-4471-B9F0-C2ADFE444AA4Q33604532-F93A46FE-E40A-455A-9944-91D2962CFBB9Q34522113-9CD0B500-CBFD-49E6-8659-11D3270EB7F4Q34656696-9DAC3E99-449B-453E-AEFA-6641D7FF2EE9Q34989637-CBE9EEA1-AD4F-4D5B-B8DE-CD386FE35A71Q35033086-99A41E7F-AD88-4745-9D85-B60802581DD1Q35447239-784E411D-B6FA-4204-8C65-03BDAA956202Q35499945-86408B79-21A9-4750-8109-ADC0F77C72C0Q35848943-12890AFE-CDFC-4BE0-A640-2EF25C4D2FF3Q36035248-96B956D6-2894-4A53-8213-F2D3AF54B79CQ36091476-CBD0BD05-544E-4CB1-A4FA-47F29E94CC0AQ36210640-8D614E5E-F64C-4165-B0E8-A55E7AA0BBC9Q36279048-58B37371-CDA7-4724-9235-5E9D33DE9D1AQ36732899-C0717F40-4EB0-4D89-800B-45638F76425EQ37196381-A4ED7D11-985A-4580-8E5E-464287482152Q38182842-AA26687B-AA57-479A-81A8-5C5D7D152988Q38367252-D6BE2455-5C27-4F4C-AA41-275343B9E217Q38803289-0B229D79-D924-4160-826A-96305E5BEC79Q38838870-A259B692-C1FC-4562-BB25-FE3D58842C99Q38998448-C7DE2B5D-91AF-40DC-8E19-3DBE33BA56ECQ39209888-6DEAB474-A465-400E-842B-4ED3EFA5397BQ39855970-8CB846FF-2242-44DF-A01F-708A84D0005AQ41279177-29244845-AD90-436F-B1BF-13C362D503C6Q41639858-238B2BE5-7562-46C1-B80A-CD9F409DE84DQ41827089-36AA1FD2-8B34-40B2-9014-77343853CAA8Q47557869-F77F2FE5-745F-4A16-9A70-5E4DB7504D88Q47558526-37C5FB3E-5F80-4759-A1FA-D24242925CA4Q47737322-0B4FDDA7-DEAC-49CD-841A-F55C2187A7BDQ49113515-CA5BF147-3F1F-4F01-83BE-BE6C38A0D077Q49874897-5A6456EA-18D6-472A-B006-C107F4DD092AQ55000556-A51FE3AB-65CC-4D7C-92B6-1138A0C86D66
P2860
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Withdrawal versus continuation ...... in older people with dementia
@ast
Withdrawal versus continuation ...... in older people with dementia
@en
Withdrawal versus continuation ...... in older people with dementia
@en-gb
Withdrawal versus continuation ...... in older people with dementia
@nl
type
label
Withdrawal versus continuation ...... in older people with dementia
@ast
Withdrawal versus continuation ...... in older people with dementia
@en
Withdrawal versus continuation ...... in older people with dementia
@en-gb
Withdrawal versus continuation ...... in older people with dementia
@nl
prefLabel
Withdrawal versus continuation ...... in older people with dementia
@ast
Withdrawal versus continuation ...... in older people with dementia
@en
Withdrawal versus continuation ...... in older people with dementia
@en-gb
Withdrawal versus continuation ...... in older people with dementia
@nl
P2093
P2860
P3181
P1476
Withdrawal versus continuation ...... in older people with dementia
@en
P2093
An IM De Sutter
Majda Azermai
Mirko Petrovic
Robert Vander Stichele
Thierry Christiaens
Tom Declercq
P2860
P3181
P356
10.1002/14651858.CD007726.PUB2
P577
2013-03-28T00:00:00Z